Kusajili – Clinical trials directory

BI 44370 TA in Acute Migraine Attack The objective of this trial is to assess the safety, tolerability, and efficacy of three doses of BI 44370 TA in the treatment of patients with an acute migraine attack and headache pain of moderate or severe intensity, compared to placebo and an active comparator.

• Country Belgium, El Salvador, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom,
• organs None
• Specialty None